Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
The fourth batch of national Chinese patent medicine alliance procurement bid opening covers 89 commonly used clinical medicines
On April 30th, the fourth batch of the National Chinese Patent Medicine Alliance Procurement (referred to as “National Joint Procurement”) opened bids in Wuhan and announced the proposed winning results.
This centralized procurement included 28 procurement groups and 89 types of medicines, with over 40k medical institutions across the country participating in submitting bids.
A total of 344 companies with 468 products met the bidding requirements, and 243 companies with 310 products were selected.
Overall, companies actively participated in bidding, with a complete range of approved dosage forms and specifications, and the mainstream products currently used in clinical practice were generally selected, effectively meeting clinical medication needs. (People’s Financial News)